Substituted diketopiperazines and their use as oxytocin antagonists

Details for Australian Patent Application No. 2004251868 (hide)

Owner Glaxo Group Limited

Inventors Liddle, John

Agent Davies Collison Cave

Pub. Number AU-B-2004251868

PCT Pub. Number WO2005/000840

Priority 0314738.6 24.06.03 GB

Filing date 22 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 22 January 2009

International Classifications

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000840 Priority application(s): WO2005/000840

22 January 2009 Application Accepted

  Published as AU-B-2004251868

21 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251876-Process for preparing intermediates useful to prepare certain antibacterial N-formyl hydroxylamines

2004251867-Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor